Thermogenic Effect of Ginger

June 20, 2017 updated by: Adaliene Versiani M. Ferreira, Federal University of Minas Gerais

Double-blind Placebo-controlled Clinical Trial of Thermogenic Effect of Ginger (Zingiber Officinale) in Eutrophic Women

The main objective of the study is to evaluate the thermogenic effect of ginger.

Study Overview

Status

Completed

Conditions

Detailed Description

Healthy and eutrophic women will receive capsules of 200 mg of ginger extract (5% active ingredient) or placebo (cellulose), along with a standardized breakfast, with a minimum seven days washout period.

Study Type

Interventional

Enrollment (Actual)

20

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Minas Gerais
      • Belo Horizonte, Minas Gerais, Brazil, 30130-100
        • Hospital das Clínicas

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 60 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Female

Description

Inclusion Criteria:

  • Females;
  • Aged between 18 and 60 years old;
  • Body mass index between 18.5 and 24.9 kg/m²;
  • Agree to sign the informed consent.

Exclusion Criteria:

  • Any chronic health conditions (e.g. diabetes, hypertension, chronic renal failure, heart and liver disease);
  • Previous operation for weight loss;
  • Medications known to affect total energy expenditure;
  • Pregnancy and breast-feeding;
  • Smoking;
  • Alcohol use (>2 doses/day).

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: Triple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Extract of ginger
Healthy and eutrophic women will receive two capsules of 200 mg of ginger extract (5% gingerols) to be taken along with a standardized breakfast.
The volunteers will receive two capsules containing 200mg of extract of ginger with 5% of gingerols (20 mg). Breakfast will be offered (bread, butter, turkey ham and industrialized fruit juice) and the participants will have 15 minutes to eat it.
Placebo Comparator: Cellulose
Healthy and eutrophic women will receive two capsules of 200 mg of placebo (cellulose) to be taken along with a standardized breakfast.
The volunteers will receive two capsules containing cellulose (placebo). Breakfast will be offered (bread, butter, turkey ham and industrialized fruit juice) and the participants will have 15 minutes to eat it.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in postprandial energy expenditure
Time Frame: Baseline and thereafter at 30, 60, 120, 180 and 240 minutes postprandial
Energy expenditure will be assessed by indirect calorimetry
Baseline and thereafter at 30, 60, 120, 180 and 240 minutes postprandial

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in oxygen consumption
Time Frame: Baseline and thereafter at 30, 60, 120, 180 and 240 minutes postprandial
Oxygen consumption will be assessed by indirect calorimetry
Baseline and thereafter at 30, 60, 120, 180 and 240 minutes postprandial
Change in blood pressure
Time Frame: Baseline and thereafter at 30, 60, 120, 180 and 240 minutes postprandial
Blood pressure will be assessed using digital sphygmomanometer
Baseline and thereafter at 30, 60, 120, 180 and 240 minutes postprandial
Change in axillary temperature
Time Frame: Baseline and thereafter at 30, 60, 120, 180 and 240 minutes postprandial
Axillary temperature will be assessed using a digital thermometer
Baseline and thereafter at 30, 60, 120, 180 and 240 minutes postprandial
Change in metabolic profile
Time Frame: Baseline and thereafter at 30, 60, 120 and 240 minutes postprandial
Total cholesterol
Baseline and thereafter at 30, 60, 120 and 240 minutes postprandial
Change in heart rate
Time Frame: Baseline and thereafter at 30, 60, 120, 180 and 240 minutes postprandial
Heart rate will be assessed using digital sphygmomanometer
Baseline and thereafter at 30, 60, 120, 180 and 240 minutes postprandial
Change in metabolic profile
Time Frame: Baseline and thereafter at 30, 60, 120 and 240 minutes postprandial
Glucose levels
Baseline and thereafter at 30, 60, 120 and 240 minutes postprandial
Change in metabolic profile
Time Frame: Baseline and thereafter at 30, 60, 120 and 240 minutes postprandial
HDL-cholesterol
Baseline and thereafter at 30, 60, 120 and 240 minutes postprandial

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Chair: Gabriela BP Fagundes, Federal University of Minas Gerais

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 27, 2017

Primary Completion (Actual)

June 14, 2017

Study Completion (Actual)

June 14, 2017

Study Registration Dates

First Submitted

March 8, 2017

First Submitted That Met QC Criteria

March 19, 2017

First Posted (Actual)

March 24, 2017

Study Record Updates

Last Update Posted (Actual)

June 21, 2017

Last Update Submitted That Met QC Criteria

June 20, 2017

Last Verified

June 1, 2017

More Information

Terms related to this study

Other Study ID Numbers

  • UFMG 30409114.8.0000.5149

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

Undecided

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Healthy Volunteers

Clinical Trials on Extract of ginger

3
Subscribe